Cardinal Health, Inc. (NYSE:CAH) UBS Global Healthcare Conference November 12, 2024 11:00 AM ET Company Participants Matt Sims - Vice President, Investor Relations Aaron Alt - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Kevin Caliendo Good morning, everybody. Welcome to the UBS Healthcare Global Healthcare Conference. I'm Kevin Caliendo, health care, IT and distribution analyst. And with us this morning is the management of Cardinal Health. Aaron Alt, CFO; and Matt Sims, Direct ...

Cardinal Health (CAH) recently announced that it has entered into definitive agreements to acquire two companies. These agreements are likely to accelerate Cardinal Health's strategic growth areas along with enhancing patient care. CAH is likely to acquire a majority stake in GI Alliance ("GIA"), along with acquiring the Advanced Diabetes Supply Group ("ADSG"). GIA is the country's leading gastroenterology management services organization ("MSO"), from a combination of GIA physician owners and funds managed ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Cardinal Health (CAH) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question. Cardinal Health is one of 1024 companies in the Medical group. The Medical group currently sits at #3 ...

Southlake, Texas, Nov. 11, 2024 (GLOBE NEWSWIRE) -- GI Alliance (GIA) announced today that it has entered into a definitive agreement with Cardinal Health (NYSE: CAH) through which Cardinal Health will acquire a majority stake in GIA, a physician-led, national management services organization supporting independent gastroenterology practices from a combination of GIA physician owners and funds managed by affiliates of Apollo (NYSE: APO).  The transaction values GI Alliance at $3.9 billion. “GI Alliance and ...

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition of the Advanced Diabetes Supply Group, a leading national direct-to-patient provider of diabetes medical supplies, to accelerate Cardinal Health's at-Home Solutions growth strategy Company announces plan to hold Investor Day in June 2025 DUBLIN, Ohio, Nov. 11, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) annou ...

Michael (Mike) Dion is an FP&A, Corporate Finance, and Small Business expert who spent the last 12 years working in the Fortune 100, building a startup's finance and accounting department, advising small businesses, and guiding non-profit organizations as a board member. He has finance experience across multiple industries, including Telecom, Media and Entertainment, Hospitality, and Construction. He founded F9 Finance, a website that helps Finance professionals accelerate their careers; and simplifies Fina ...

Key TakeawaysCardinal Health beat first-quarter profit and sales estimates on growing demand by existing customers.Revenue fell at the healthcare products company's biggest division, Pharmaceutical & Specialty Solutions, but would have been up 16% year-over-year had it not lost a big contract with a benefits manager.Cardinal Health raised its full-year EPS guidance and shares set a new all-time intraday high. Cardinal Health (CAH) shares hit a new all-time intraday high Friday as the healthcare products pro ...

Cardinal Health, Inc. (NYSE:CAH) Q1 2025 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Officer Aaron Alt - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Michael Cherny - Leerink Partners Erin Wright - Morgan Stanley Eric Percher - Nephron Research Allen Lutz - Bank of America Kevin Caliendo - UBS Eric Coldwell - Baird George Hill - Deutsche Bank Stephanie Davis - Barclays Eli ...

Cardinal Health, Inc.(CAH) reported first-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.88, which beat the Zacks Consensus Estimate of $1.64 by 9.8%. The bottom line also improved 9.3% year over year.GAAP EPS in the quarter was $1.70 against a loss of 5 cents per share in the year-ago period.Revenue DetailsSales declined 4.3% on a year-over-year basis to $52.28 billion. However, the top line beat the Zacks Consensus Estimate by 2%.Segmental AnalysisPharmaceutical and Specialty Solutions Pharma ...

For the quarter ended September 2024, Cardinal Health (CAH) reported revenue of $52.28 billion, down 4.5% over the same period last year. EPS came in at $1.88, compared to $1.73 in the year-ago quarter. The reported revenue represents a surprise of +1.99% over the Zacks Consensus Estimate of $51.26 billion. With the consensus EPS estimate being $1.64, the EPS surprise was +14.63%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to det ...